Get the latest Science News and Discoveries

NIH-sponsored trial of nasal COVID-19 vaccine opens - EurekAlert


A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes COVID-19, is now enrolling healthy adults at three sites in the United States. The National Institutes of Health (NIH) is sponsoring the first-in-human trial of the investigational vaccine, which was designed and tested in pre-clinical studies by scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) Laboratory of Infectious Diseases. 

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of COVID-19

COVID-19

Photo of EurekAlert

EurekAlert

Photo of sponsored trial

sponsored trial

Related news:

News photo

Dehumanizing rhetoric on immigration harms public health - EurekAlert

News photo

Research-driven Korea University College of Medicine promotes joint research with global scholars - EurekAlert

News photo

AI-powered study explores under-studied female evolution - EurekAlert